| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |